Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage

被引:171
作者
Grilli, M [1 ]
Barbieri, I [1 ]
Basudev, H [1 ]
Brusa, R [1 ]
Casati, C [1 ]
Lozza, G [1 ]
Ongini, E [1 ]
机构
[1] Schering Plough Res Inst, Dept CNS CV Res, I-20132 Milan, Italy
关键词
cerebral ischaemia; cytokines; interleukin-10; knock-out mice; neurodegeneration; neuroprotection;
D O I
10.1046/j.1460-9568.2000.00090.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-10 (IL-10) is a powerful suppressor of cellular immune responses, with a postulated role in brain inflammation. First, we have evaluated the role of this cytokine in ischaemic brain damage using IL-10 knockout (IL-10(-/-)) mice. The middle cerebral artery (MCA) was occluded in either IL-10(-/-) or wild-type animals of corresponding strain (C57Bl/6) and age. Infarct volume was assessed 24 h later in serial brain sections. Brain infarct produced by MCA occlusion was 30% larger in the IL-10(-/-) than in wild-type mice (21.8 +/- 1.2 vs. 16.9 +/- 1.0 mm(3), respectively; P < 0.01; Student's t-test). To further characterize these findings, studies were extended to in vitro models. Primary neuronal cortical cultures derived from IL-10(-/-) animals were more susceptible to both excitotoxicity and combined oxygen-glucose deprivation compared with cell cultures from wild-type mice. Moreover, when added to the culture medium, recombinant murine IL-10 (0.1-100 ng/mL) exerted a concentration-dependent prevention of neuronal damage induced by excitotoxicity in both cortical and cerebellar granule cell cultures taken from either strain. The accordance of in vivo and in vitro data allows us to suggest a potential neuroprotective role of IL-10 against cerebral ischaemia when administered exogenously or made available from endogenous sources.
引用
收藏
页码:2265 / 2272
页数:8
相关论文
共 38 条
[1]   RAT MIDDLE CEREBRAL-ARTERY OCCLUSION - EVALUATION OF THE MODEL AND DEVELOPMENT OF A NEUROLOGIC EXAMINATION [J].
BEDERSON, JB ;
PITTS, LH ;
TSUJI, M ;
NISHIMURA, MC ;
DAVIS, RL ;
BARTKOWSKI, H .
STROKE, 1986, 17 (03) :472-476
[2]  
Bell MJ, 1997, ACT NEUR S, V70, P96
[3]   DIFFERENTIAL REGULATION OF ASTROCYTE TNF-ALPHA EXPRESSION BY THE CYTOKINES TGF-BETA, IL-6 AND IL-10 [J].
BENVENISTE, EN ;
TANG, LP ;
LAW, RM .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1995, 13 (3-4) :341-349
[4]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[5]  
BERKMAN N, 1995, J IMMUNOL, V155, P4412
[6]   Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats [J].
Bethea, JR ;
Nagashima, H ;
Acosta, MC ;
Briceno, C ;
Gomez, F ;
Marcillo, AE ;
Loor, K ;
Green, J ;
Dietrich, WD .
JOURNAL OF NEUROTRAUMA, 1999, 16 (10) :851-863
[7]   Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes [J].
Brodie, C .
FEBS LETTERS, 1996, 394 (02) :117-120
[8]  
CHAO CC, 1992, J IMMUNOL, V149, P2736
[9]   Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-κB in rats [J].
Clemens, JA ;
Stephenson, DT ;
Yin, TG ;
Smalstig, EB ;
Panetta, JA ;
Little, SP .
STROKE, 1998, 29 (03) :677-682
[10]  
Diab A, 1997, J NEUROPATH EXP NEUR, V56, P641